EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Patient‐led innovation and global health justice: Open‐source digital health technology for type 1 diabetes care

Bianca Jansky, Tereza Hendl, Azakhiwe Z Nocanda

Bioethics · 2024

DOI: 10.1111/bioe.13205 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioethics, 2024. Verfasst von Bianca Jansky und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Ethics and History of Health in Society, University of Augsburg, Augsburg, Germany. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Global Health, Social Justice. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Bundesministerium für Bildung und Forschung, BMBF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Health innovation is mainly envisioned in direct connection to medical research institutions or pharmaceutical and technology companies. Yet, these types of innovation often do not meet the needs and expectations of individuals affected by health conditions. With the emergence of digital health technologies and social media, we can observe a shift, which involves people living with illness modifying and improving medical and health devices outside of the formal research and development sector, figuring both as users and innovators. This patient‐led innovation has been celebrated in innovation studies and economics as a “bottom‐up” type of innovation. In this article, we take a closer look at open‐source patient‐led innovation in the context of type 1 diabetes care. In our inquiry, we pay particular attention to the social and ethical dimensions of this innovation, building on empirical material. Upon exploring the notion of patient‐led innovation and its socio‐political context through the lens of intersectional and global health justice, we argue that a proactive strategy is needed to ensure that open‐source patient‐led innovation will be more globally accessible, center the health needs of the most underserved populations, as well as facilitate equitable and just health benefits. To support this aim, we provide a range of examples of different initiatives addressing the persistent inequalities that have so far inhibited patient‐led innovation from more fully materializing its innovative potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Global HealthSocial JusticeHumansBiomedical TechnologyDigital TechnologySocial MediaPatient ParticipationDigital Health

Stichwörter der Autor:innen

digital healthempirical bioethicshealth justicemHealthopen‐sourcepatient‐led innovation

Autor:innen und Institutionen

  • Institute for Ethics and History of Health in Society, University of Augsburg, Augsburg, Germany.
  • Institute of Ethics, History and Theory of Medicine, Ludwig-Maximilians-University, Munich, Germany.
  • Faculty of Social Sciences, Humboldt University, Berlin, Germany.

Förderung

  • Bundesministerium für Bildung und Forschung
  • BMBF

Zitieren

APA

Jansky, B., Hendl, T., & Nocanda, A. Z. (2024). Patient‐led innovation and global health justice: Open‐source digital health technology for type 1 diabetes care. Bioethics. https://doi.org/10.1111/bioe.13205

Vancouver

Jansky B, Hendl T, Nocanda AZ. Patient‐led innovation and global health justice: Open‐source digital health technology for type 1 diabetes care. Bioethics. 2024. doi:10.1111/bioe.13205

BibTeX
@article{Jansky2024,
  author = {Jansky, Bianca and Hendl, Tereza and Nocanda, Azakhiwe Z},
  title = {Patient‐led innovation and global health justice: Open‐source digital health technology for type 1 diabetes care},
  journal = {Bioethics},
  year = {2024},
  doi = {10.1111/bioe.13205}
}
Kostenlos starten →